Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.
Hill MD., Lye T., Moss H., Barber PA., Demchuk AM., Newcommon NJ., Green TL., Kenney C., Cole-Haskayne A., Buchan AM.
One hundred seventy-six consecutive patients treated with IV tissue plasminogen activator (tPA) for acute ischemic stroke were examined prospectively, and orolingual angioedema was found in nine (5.1%; 95% CI 2.3 to 9.5). The reaction was typically mild, transient, and contralateral to the ischemic hemisphere. Risk of angioedema was associated with angiotensin-converting enzyme inhibitors (relative risk [RR] 13.6; 95% CI 3.0 to 62.7) and signs on initial CT of ischemia in the insular and frontal cortex (RR 9.1; 95% CI 1.4 to 30.0).